The Problem.

Right now, there are hundreds of thousands dying due to unnecessary complications of hospital stays, and millions around the world suffering from conditions that affect their sleep.

The Unnecessary Complications:
Falls are a complication that seriously injure nearly 10% of patients >65 in hospital (2% of this demographic will be admitted per anum!). They alone cost my state of 7million people $558 million1, and the US upwards of $30billion2 every year! DVTs (clots) affect up to 17% of immobile patients3 and kill 15% who have them dislodge4 – costing the US $27.3 billion a year5. Pressure sores affect many in acute situations and in post-surgical recovery (or those with skin conditions). These last months to years and cost $129 000 per patient to treat, totaling a low end estimate of $11billion/year to the US6. Pneumonias are the 2nd largest cause of hospitalisation after pregnancy7. It takes over 950,000 children8, as well as many elderly, immunosuppressed and bed-bound patients disproportionately, every year.
Conditions that affect sleep:
Whilst lying flat, especially while at sleep, when your breathing is least powerful, and most encumbered, many with lung conditions find it hard to fall asleep. Examples of conditions, and the numbers affected: 70,000 Cystic Fibrosis patients9 26,000,000 Heart Failure patients10 42,000,000 Sleep Apnoea patients11 384,000,000 COPD12, and 334,000,000 Asthma Sufferers13 Furthermore, 7% of the world’s population – nearly 1/4 people in the developed world14 – plus up to 80% of expectant mothers15, suffer from acid reflux regularly! And finally, between 3 and 10% of the entire population suffer from chronic lower back pain. Over 25% of the elderly population, in fact16.

Seeing this, we knew we had to do something. Our solution? The Convertible Hospital Bed Frame, and the Adjustable Wedge Pillow. Check them out in our animation below, or read our detailed description of how they make an impact, here

1) Center for Health Advancement, The Incidence and Cost of Falls Injury Among Older People in New South Wales 2006/07., NSW Department of Health, September 2010. 2) CDC, Falls fact page, available at: https://www.cdc.gov/homeandrecreationalsafety/falls/fallcost.html 3) Janata K, Holzer M, Domanovits H, Müllner M, Bankier A, Kurtaran A, Bankl HC, Laggner AN. Mortality of patients with pulmonary embolism. Wien Klin Wochenschr. 2002 Sep 30;114(17-18):766-72. 4) SD Yang, H Liu, YP Sun, DL Yang, Y Shen, SQ Feng, FD Zhao, Wen-Yuan Ding, Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study, Nature Scientific Reports 5, Article number: 11834 (2015) 5) C.E. Mahan, M.E. Borrego, A.L. Woersching, R. Federici, R. Downey, J. Tiongson, et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates, Thromb Haemost, 108 (2) (2012), pp. 291-302 6) Harold Brem, Jason Maggi, David Nierman, Linda Rolnitzky, David Bell, Robert Rennert, Michael Golinko, Alan Yan, Courtney Lyder, Bruce Vladeck, High Cost of Stage IV Pressure Ulcers, Am J Surg. 2010 Oct; 200(4): 473–477. doi: 10.1016/j.amjsurg.2009.12.021 7) TM File, TJ Marrie, Burden of Community-Acquired Pneumonia in North American Adults, Postgrad Med. 2010 Mar;122(2):130-41. doi: 10.3810/pgm.2010.03.2130. 8) Malaria Consortium, Quoting WHO figures for under 5 year old pneumonia deaths per year: http://www.malariaconsortium.org/news-centre/worlds-first-pneumonia-innovations-summit-unveils-next-generation-prevention-diagnostic-and-treatment-innovations.htm 9) Cystic Fibrosis Foundation factpage, retrievable from https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/ 10) Ambrosy Ap, Fonarow GC, Buffer J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah A, Gheorghiade M, The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned From Hospitalized Heart Failure Registries, Journal of the American College of Cardiology, Volume 63, Issue 12, 1 April 2014, Pages 1123-1133 11) Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, Chan KY, Sheikh A, Rudan I, and Global Health Epidemiology Reference Group (GHERG), Global and regional estimates of COPD prevalence: Systematic review and meta–analysis, J Glob Health. 2015 Dec; 5(2): 020415. 12) R Pawankar, Allergic diseases and asthma; a global public health concern and a call to action, World Allergy Organization Journal20147:12, https://doi.org/10.1186/1939-4551-7-12 13) Sleep Apnea Facts and Figures, Res Med Publication; available from: http://www.quinlansmedical.com/pdf/sleep_apnea_facts_figures.pdf 14) Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R, Gastroesophageal reflux disease: A review of surgical decision making, World J Gastrointest Surg. 2016 Jan 27; 8(1): 77–83. 15) Ramya RS, Jayanthi N, Alexander PC, Vijaya S, Jayanthi V, Gastroesophageal reflux disease in pregnancy: a longitudinal study, Trop Gastroenterol. 2014 Jul-Sep;35(3):168-72 16) Hoy D, Brooks P, Blyth F, Buchbinder R, The Epidemiology of low back pain, Best Pract Res Clin Rheumatol. 2010 Dec;24(6):769-81. doi: 10.1016/j.berh.2010.10.002.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email